Grant name: RFA-CA-25-019
Funding organization: National Cancer Institute (NCI)
Total funding amount: $10 million
Funding duration: Up to 5 years
Primary objective: To support multi-level intervention studies addressing barriers to healthcare transitions for survivors of childhood and adolescent cancers.
The grant is part of the STAR Reauthorization Act of 2023.
It aims to improve long-term outcomes for cancer survivors transitioning from pediatric to adult care.
The research will establish best practices and standards of care.
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits (with and without 501(c)(3) status)
For-Profit Organizations (including Small Businesses)
Local, State, County, City, and Township Governments
Indian/Native American Tribal Governments (Federally Recognized and Other)
Federal Government Agencies
Public Housing Authorities/Indian Housing Authorities
Faith-based or Community-based Organizations
Regional Organizations
Eligible organizations must be based in the United States.
Foreign organizations are not eligible to apply.
Research on barriers to healthcare transitions for childhood and adolescent cancer survivors.
Development and testing of interventions that promote high-quality transitional care.
Survivors of childhood and adolescent cancers diagnosed between ages 0-19.
Research teams should be multidisciplinary.
Applications must describe scalability and sustainability of interventions.
Maximum direct costs per year: $499,000.
Total funding available: $10 million.
Application due date: September 17, 2025.
All applications must comply with NIH Grants Policy Statement.
Applications must follow the instructions in the Research Instructions in the How to Apply - Application Guide.